Perturbation du bilan hépatique chez un consommateur d’ecstasy

Becker, 2003, A fatal paramethoxymethamphetamine intoxication, Leg Med, 5, S138, 10.1016/S1344-6223(02)00096-2 Carrion, 2003, Ecstasy-induced fulminant hepatic failure and emergency liver transplantation, Med Clin, 12, 118 Roques, 1998, Hépatite aiguë à l’ecstasy, Presse Med, 27, 468 Carvalho, 2002, Effect of ecstasy on body temperature and liver antioxydant status in mice: influence of ambient temperature, Archives of Toxicology, 76, 166, 10.1007/s00204-002-0324-z Johnson, 2002, d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity., Brain Research, 933, 150, 10.1016/S0006-8993(02)02313-2 Andreu, 1998, Ecstasy: a common cause of severe acute hepatotoxicity, Hepatology, 29, 394, 10.1016/S0168-8278(98)80056-1 Nunez, 2002, Variability of the clinical expression of Ecstasy-induced hepatotoxicity, Gastroenterologia y Hepatologia, 25, 497 Montiel-Duarte, 2002, Ecstasy induces apoptosis of cultured rat liver cells, Biochimica et Biophysica Acta, 1588, 26, 10.1016/S0925-4439(02)00112-6 Ravina, 2004, Hyperkaliema in fatal MDMA (ecstasy) toxicity, Int J Cardiol, 93, 307, 10.1016/S0167-5273(03)00162-1 Lange-Brock, 2002, Acute liver failure following the use of ecstasy (MDMA), Z Gastroenterol, 40, 581, 10.1055/s-2002-33416 Maurer, 2004, Chemistry, pharmacology, toxicology and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine and pyrrolidinophenone types: a synopsis, The Drug Monit, 26, 127, 10.1097/00007691-200404000-00007 Carvalho, 2004, Hepatotoxicity of 3,4 – methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates, Arch Toxicol, 78, 16, 10.1007/s00204-003-0510-7 Simon, 2003, Pharmacologie et toxicologie cliniques de l’ecstasy, L’Information Psychiatrique, 3, 233